Beijing, China

Fajie Li

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 11.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Fajie Li: Innovator in Pharmaceutical Research

Introduction

Fajie Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating various diseases. With a total of four patents to his name, Li's work is recognized for its potential impact on medical treatments.

Latest Patents

Fajie Li's latest patents include a Rho-associated protein kinase inhibitor, which is a pharmaceutical composition designed to prevent or treat ROCK-mediated diseases. This invention is represented by a specific formula and highlights the importance of targeting Rho-associated protein kinases in therapeutic applications. Another notable patent is a receptor inhibitor, which also includes a pharmaceutical composition and its uses, showcasing Li's commitment to advancing medical science through innovative solutions.

Career Highlights

Li is currently associated with Beijing Tide Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the industry.

Collaborations

Fajie Li collaborates with esteemed colleagues such as Yanping Zhao and Hongjun Wang. These partnerships enhance the research environment and foster innovation within the pharmaceutical sector.

Conclusion

Fajie Li's contributions to pharmaceutical research through his patents and collaborations underscore his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, reflecting his dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…